Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials.
Publication
, Journal Article
Li, G; Crowley, MJ; Tang, H; Yang, JY; Sandler, RS; Wang, T
Published in: Diabetes Care
July 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Diabetes Care
DOI
EISSN
1935-5548
Publication Date
July 2019
Volume
42
Issue
7
Start / End Page
e119 / e121
Location
United States
Related Subject Headings
- Endocrinology & Metabolism
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Li, G., Crowley, M. J., Tang, H., Yang, J. Y., Sandler, R. S., & Wang, T. (2019). Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials. Diabetes Care, 42(7), e119–e121. https://doi.org/10.2337/dc18-1578
Li, Guangyao, Matthew J. Crowley, Huilin Tang, Jeff Y. Yang, Robert S. Sandler, and Tiansheng Wang. “Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials.” Diabetes Care 42, no. 7 (July 2019): e119–21. https://doi.org/10.2337/dc18-1578.
Li G, Crowley MJ, Tang H, Yang JY, Sandler RS, Wang T. Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials. Diabetes Care. 2019 Jul;42(7):e119–21.
Li, Guangyao, et al. “Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials.” Diabetes Care, vol. 42, no. 7, July 2019, pp. e119–21. Pubmed, doi:10.2337/dc18-1578.
Li G, Crowley MJ, Tang H, Yang JY, Sandler RS, Wang T. Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials. Diabetes Care. 2019 Jul;42(7):e119–e121.
Published In
Diabetes Care
DOI
EISSN
1935-5548
Publication Date
July 2019
Volume
42
Issue
7
Start / End Page
e119 / e121
Location
United States
Related Subject Headings
- Endocrinology & Metabolism
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences